Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality.

Authors :: Collet, Tinh-Hai
Gussehloo, Jacobijn
Bauer, Douglas C.
den Elzen, Wendy P. J.
Cappola, Anne R.
Balmer, Philippe
Iervasi, Giorgiò
Åsvold, Bjørn O.
Sgarbi, José A.
Völzke, Henry
Gencer, Bariş
Macie!, Rui M. B.
Molinaro, Sabrina
Bremner, Alexandra
Luben, Robert N.
Maisonneuve, Patrick
Cornuz, Jacques
Newman, Anne B.
Kay-Tee Khaw
Westendorp, Rudi G. J.
Source :: Archives of Internal Medicine. 5/28/2012, Vol. 172 Issue 10, p799-809. 11p.
Publication Year :: 2012
Abstract: The article details a study which examined the risks of total and coronary heart disease (CHD) mortality, CHD events, and atrial fibrillation (AF) associated with endogenous subclinical hyperthyroidism. Of the 52,674 study subjects, 4.2 percent were found to have clinical hyperthyroidism. Study authors concluded that endogenous subclinical hyperthyroidism is associated with increased risks of total and CHD mortality, and AF development.

Subjects :: *CORONARY disease
*ATRIAL fibrillation
*HYPERTHYROIDISM
*MORTALITY
*ATRIAL arrhythmias

Full Text Access

Tools